Loading...
| A03873 | Pages: NA | Aug 2021 | 3644 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Serum-free Freezing Media Market
Request Now !In serum-free freezing media market cells, tissues, organs, or organelles are susceptible to damage at normal temperatures by unregulated chemical kinetics and are conserved by freezing to a very low temperature. The procedure is known as cryopreservation, which is carried out with the help of various types of serums or media.
Cell freezing media commonly includes a source of protein, base medium, and a cryo-preservative that prevents any physical and mechanical damage to cell and eliminates water content inside the cell.
Increase in application and advantages of cell freezing in drug development and research is expected to drive the market. In addition, rise in government initiatives for research in biopharmaceutical industry boosts the growth of this market. However, lack of efficient research infrastructure and high maintenance cost for research facilities impedes the growth of the serum-free freezing media market.
The global serum-free freezing media market is segmented on the basis of type of media, end user, and geography. By type of media, it is classified into Chinese hamster ovary (CHO) cell media, insect media, hybridoma media, and vaccine production media. Based on end user, the market is divided into biopharmaceutical companies, pharmaceutical companies, and academics and research. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. These regions are further analyzed across the globe at country level to determine the market size and forecast for each segment and sub-segment.
Comprehensive competitive analysis and profiles of major market players such as Merck KGaA, Thermo Fisher Scientific Inc., Nippon Genetics, Miltenyi Biotec, Mediatech Inc., General Electric Company, BioLifeSolutions Inc., HiMedia Laboratories, Biological Industries, and PromoCell GmbH are provided in this report.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 GLOBAL SERUM-FREE FREEZING MEDIA MARKET, BY TYPE OF MEDIA
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. CHINESE HAMSTER OVARY (CHO) CELL MEDIA
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. INSECT MEDIA
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. HYBRIDOMA MEDIA
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. VACCINE PRODUCTION MEDIA
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
CHAPTER 5 GLOBAL SERUM-FREE FREEZING MEDIA MARKET, BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. BIOPHARMACEUTICAL COMPANIES
5.2.1. Market size and forecast
5.3. PHARMACEUTICAL COMPANIES
5.3.1. Market size and forecast
5.4. ACADEMICS AND RESEARCH
5.4.1. Market size and forecast
CHAPTER 6 SERUM-FREE FREEZING MEDIA MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1. MERCK KGAA
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. THERMO FISHER SCIENTIFIC INC
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. NIPPON GENETICS
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. MILTENYI BIOTEC
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. MEDIATECH INC.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. GENERAL ELECTRIC COMPANY
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. BIOLIFESOLUTIONS INC
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. HIMEDIA LABORATORIES
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. BIOLOGICAL INDUSTRIES
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. PROMOCELL GMBH
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
